Product Details
Product Name:
Mepolizumab |
CAS No.:
196078-29-2 |
Purity:
98% |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | Mepolizumab |
Description | Mepolizumab (SB 240563) is a humanized monoclonal antibody that neutralizes IL-5, and can be utilized in research on severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis. |
Storage | store at -20°C | Shipping with blue ice. |
Keywords | eosinophil proliferation | neutralizes interleukin-5 | Interleukin Related | IL-5 | SB240563 | eosinophilic granulomatosis | humanized monoclonal antibody | polyangiitis | Inhibitor | EGPA | SB-240563 | activation | Mepolizumab | eosinophilic asthma | survival | inhibit |
Inhibitors Related | Inosine pranobex | L-Arginine | Diallyl disulfide |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:1776115-10-6
$43.00 / 5mg
-
CAS:232271-19-1
$48.00 / 1mg
-
CAS:53931-25-2
$130.00 / 5mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |